Bonafide’s 2025 ‘State of Menopause Report’ Reveals Women Are Still Suffering in Silence

We may earn commission from links on this page. Each product featured has been vetted and chosen by our editors.
Bonafide’s 2025 ‘State of Menopause Report’ Reveals Women Are Still Suffering in Silence featured image
Photo by Maria Kovalets on Unsplash

Bonafide offers a holistic approach to perimenopause and menopause care. The brand offers hormone-free solutions to common symptoms as well as in-depth education. Since 2021, Bonafide has been collecting data each year on where awareness, education and experiences of menopause stand. Although there’s been marked improvement over the past five years, there’s still plenty of room to grow.

The 2025 report found that 59 percent of women aged 40 to 49 had never even heard of perimenopause until they began experiencing the symptoms. Furthermore, 71 percent of women report feeling unprepared for how disruptive symptoms are to their life.

The report found that half of women aged 40 to 49 say their menopause symptoms “caused them to feel ‘not like themselves,’ changing their mood, mind and expectations for the future.” The effects extend beyond women’s personal life, with three in four women reporting that perimenopause has negatively affected at least one aspect of their work life, and one in five saying it impacted their income.

While, unfortunately, perimenopause can’t be skipped completely, the symptoms can be managed, which could make a significant difference in women’s quality of life. Meanwhile, 69 percent of women are not using any treatments for their symptoms. In 2025, we’re luckily far beyond suffering in silence, with many easily accessible solutions available. Bonafide offers non-hormonal options for hot flashes, vaginal dryness, sexual satisfaction and more.

Related Posts

Find a Doctor

Find a NewBeauty "Top Beauty Doctor" Near you

NewBeauty cover with reflection

Give the Gift of Luxury

NewBeauty uses cookies for various reasons, including to analyze and improve its content and advertising. Please review our Privacy Policy and Terms of Use for more about how we use this data. By continuing to use this site, you agree to these policies.